ArticleCancer chemotherapy and pharmacology2024

The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis.

Yukio Tonozuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.